Literature DB >> 1141451

Anticoagulant activity of heparin in intravenous fluids.

T Okuno, C A Nelson.   

Abstract

The anticoagulant activity of heparin dissolved in intravenous solutions was measured by two different methods of heparin assay. Both procedures showed markedly reduced anticoagulant activity within four hours after the addition of heparin to the solutions. When measured according to the procedure of Yin, heparin in the intravenous solutions fully regained its lost anticoagulant activity after 24 hours at room temperature. When measured by the thrombin time, however, the heparin anticoagulant activity reamained reduced. The source of heparin, from either the lung or intestine, does not explain the reduction in anticoagulant activity. Although its cause is unknown, the erratic behaviour of heparin in intravenous solutions stresses the importance of a laboratory monitor of heparin therapy.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1141451      PMCID: PMC475749          DOI: 10.1136/jcp.28.6.494

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  8 in total

1.  CLINICAL EXPERIENCES OF A SURGEON IN THE USE OF HEPARIN.

Authors:  G BAUER
Journal:  Am J Cardiol       Date:  1964-07       Impact factor: 2.778

Review 2.  Guidelines for heparin therapy.

Authors:  E Genton
Journal:  Ann Intern Med       Date:  1974-01       Impact factor: 25.391

3.  Monitoring heparin therapy in hemodialysis. A report on the activated whole blood coagulation time tests.

Authors:  J E Congdon; C G Kardinal; J D Wallin
Journal:  JAMA       Date:  1973-12-24       Impact factor: 56.272

4.  Plasma heparin: a unique, practical, submicrogram-sensitive assay.

Authors:  E T Yin; S Wessler; J V Butler
Journal:  J Lab Clin Med       Date:  1973-02

5.  Heparin in acid solutions.

Authors:  S L Stock; N Warner
Journal:  Br Med J       Date:  1971-07-31

6.  Intravenous infusions of heparin and penicillins.

Authors:  J Jacobs; D Kletter; E Superstine; K R Hill; B Lynn; R A Webb
Journal:  J Clin Pathol       Date:  1973-10       Impact factor: 3.411

7.  Control of heparin therapy.

Authors:  W R Pitney; J E Pettit; L Armstrong
Journal:  Br Med J       Date:  1970-10-17

8.  Dextrose and sorbitol as diluents for continuous intravenous heparin infusion.

Authors:  J M Chessells; T A Braithwaite; D A Chamberlain
Journal:  Br Med J       Date:  1972-04-08
  8 in total
  3 in total

1.  Letter: Heparin in intravenous fluids.

Authors:  C G Raper; E Johnson
Journal:  J Clin Pathol       Date:  1976-04       Impact factor: 3.411

2.  Stability of heparin in intravenous fluids.

Authors:  G A Shah; T Z Dhall; I A Ferguson; M R Davis; D P Dhall
Journal:  J Clin Pathol       Date:  1980-12       Impact factor: 3.411

3.  Heparin stability: effects of diluent, heparin activity, container, and pH.

Authors:  K T Goodall; C C Chooi; A S Gallus
Journal:  J Clin Pathol       Date:  1980-12       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.